Your browser doesn't support javascript.
loading
Codon-Restrained Method for Both Eliminating and Creating Intragenic Bacterial Promoters.
Logel, Dominic Y; Trofimova, Ellina; Jaschke, Paul R.
Afiliação
  • Logel DY; School of Natural Sciences, ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney 2109, New South Wales, Australia.
  • Trofimova E; School of Natural Sciences, ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney 2109, New South Wales, Australia.
  • Jaschke PR; School of Natural Sciences, ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney 2109, New South Wales, Australia.
ACS Synth Biol ; 11(2): 689-699, 2022 02 18.
Article em En | MEDLINE | ID: mdl-35043622
ABSTRACT
Future applications of synthetic biology will require refactored genetic sequences devoid of internal regulatory elements within coding sequences. These regulatory elements include cryptic and intragenic promoters, which may constitute up to a third of the predicted Escherichia coli promoters. The promoter activity is dependent on the structural interaction of core bases with a σ factor. Rational engineering can be used to alter key promoter element nucleotides interacting with σ factors and eliminate downstream transcriptional activity. In this paper, we present codon-restrained promoter silencing (CORPSE), a system for removing intragenic promoters. CORPSE exploits the DNA-σ factor structural relationship to disrupt σ70 promoters embedded within gene coding sequences with a minimum of synonymous codon changes. Additionally, we present an inverted CORPSE system, iCORPSE, which can create highly active promoters within a gene sequence while not perturbing the function of the modified gene.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator sigma / Escherichia coli Tipo de estudo: Prognostic_studies Idioma: En Revista: ACS Synth Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator sigma / Escherichia coli Tipo de estudo: Prognostic_studies Idioma: En Revista: ACS Synth Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália